
Loading, please wait...

Loading, please wait...

Recent research highlights that serum copper and hyperuricemia show a significant positive association among the adolescent population. This observational study suggests that elevated copper levels may serve as a potential risk factor for metabolic complications. Researchers analyzed data from the National Health and Nutrition Examination Survey (NHANES) involving 1,034 participants aged 12 to 19 years. They found that 13.44% of the participants suffered from hyperuricemia, a condition often preceding gout and metabolic syndrome.
Exploring the biological link between serum copper and hyperuricemia is essential for effective clinical management. Copper is an essential trace element that plays a vital role in several physiological processes. However, excessive levels can interfere with uric acid metabolism. Specifically, copper may act as an activator for xanthine oxidase, the enzyme responsible for converting purines into uric acid. Consequently, higher concentrations of copper in the blood often correlate with increased serum uric acid levels.
Furthermore, the study revealed that each 1-unit increase in serum copper concentration leads to a 5% higher prevalence of hyperuricemia. Although the association was absent in unadjusted models, it became statistically significant after controlling for demographic and health-related confounders. Therefore, monitoring trace element levels could be a valuable addition to metabolic screenings for youth.
The findings underscore the importance of early intervention in managing adolescent metabolic health. Since hyperuricemia is a precursor to several chronic diseases, identifying modifiable risk factors like serum copper is critical. Additionally, this association remained consistent across various subgroups, reinforcing its potential as a broad clinical indicator. Nevertheless, longitudinal studies are still required to validate these findings and clarify the underlying causal mechanisms.
Elevated serum copper may activate xanthine oxidase, an enzyme that increases the production of uric acid, thereby raising the risk of hyperuricemia.
The study found that every 1-unit increase in serum copper concentration was associated with a 5% higher prevalence of hyperuricemia in adolescents.
Hyperuricemia is strongly linked to the development of gout and metabolic syndrome, making early detection and management vital for long-term health.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
Wu Y et al. The association between serum copper levels and hyperuricemia in adolescents: an observational study. Eur J Med Res. 2026 Feb 20. doi: 10.1186/s40001-026-04078-5. PMID: 41721441.
Li H et al. Association between serum copper levels and prevalence of hyperuricemia: a cross-sectional study. Sci Rep. 2020 May 26;10(1):8695. doi: 10.1038/s41598-020-65731-y.
Zhang Y et al. Associations between blood essential metal mixture and serum uric acid: a cross-sectional study. Front Public Health. 2023 Aug 21;11:1230671. doi: 10.3389/fpubh.2023.1230671.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new observational study identifies a significant positive association between elevated serum copper levels and the prevalence of hyperuricemia in adolesce...
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today